Imbruvica

FDA expands approved use of Imbruvica for chronic lymphocytic leukemia

[wa_restricted roles="Practice Member" login_label="Log in" message="Log on to view restricted content."]
Restricted content
[/wa_restricted]

[wa_restricted roles="not:Industry Partner" message="Log on to view restricted content."]
Restricted content
[/wa_restricted]